These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1832402)

  • 1. Novel vasopressin receptor ligands.
    Howl J; Kerr I; Chan CH; Wheatley M
    Biochem Soc Trans; 1991 Apr; 19(2):87S. PubMed ID: 1832402
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of the human liver vasopressin receptor. Profound differences between human and rat vasopressin-receptor-mediated responses suggest only a minor role for vasopressin in regulating human hepatic function.
    Howl J; Ismail T; Strain AJ; Kirk CJ; Anderson D; Wheatley M
    Biochem J; 1991 May; 276 ( Pt 1)(Pt 1):189-95. PubMed ID: 2039469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of a vasopressin antagonist with vasopressin receptors in the septum of the rat brain.
    Dorsa DM; Brot MD; Shewey LM; Meyers KM; Szot P; Miller MA
    Synapse; 1988; 2(3):205-11. PubMed ID: 2975069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist.
    Yamamura Y; Ogawa H; Chihara T; Kondo K; Onogawa T; Nakamura S; Mori T; Tominaga M; Yabuuchi Y
    Science; 1991 Apr; 252(5005):572-4. PubMed ID: 1850553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 125I-d(CH2)5[Tyr(Me)2, Tyr(NH2)9]AVP: iodination and binding characteristics of a vasopressin receptor ligand.
    Elands J; Barberis C; Jard S; Lammek B; Manning M; Sawyer WH; de Kloet ER
    FEBS Lett; 1988 Mar; 229(2):251-5. PubMed ID: 2964381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926.
    Stassen FL; Heckman G; Schmidt D; Nambi P; Aiyar N; Landvatter S; Crooke ST
    Mol Pharmacol; 1987 Mar; 31(3):267-72. PubMed ID: 2951585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotinyl analogues of vasopressin as biologically active probes for vasopressin receptor expression in cultured cells.
    Jans DA; Bergmann L; Peters R; Fahrenholz F
    J Biol Chem; 1990 Aug; 265(24):14599-605. PubMed ID: 2143764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubilization and reconstitution of vasopressin V1 receptors of rat liver.
    Aiyar N; Nambi P; Stassen F; Crooke ST
    Mol Pharmacol; 1987 Jul; 32(1):34-6. PubMed ID: 2955212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescent and biotinylated linear peptides as selective bifunctional ligands for the V1a vasopressin receptor.
    Howl J; Wang X; Kirk CJ; Wheatley M
    Eur J Biochem; 1993 Apr; 213(2):711-9. PubMed ID: 8477743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological evidence for the existence of receptors for endothelin and vasopressin on cultured astrocytes of rat spinal cord and brainstem.
    Hösli L; Hösli E; Lefkovits M; Wagner S
    Neurosci Lett; 1991 Oct; 131(2):193-5. PubMed ID: 1662342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the affinity of the vasopressin receptor by magnesium ions.
    González CB; Reyes CE; Caorsi CE; Troncoso S
    Biochem Int; 1992 Mar; 26(4):759-66. PubMed ID: 1535196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal exposure to vasopressin decreases vasopressin binding sites in the adult kidney.
    Handelmann GE; Sayson SC
    Peptides; 1984; 5(6):1217-9. PubMed ID: 6099566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist-induced down-regulation of the angiotensin II receptor in primary cultures of rat hepatocytes.
    Bouscarel B; Wilson PB; Blackmore PF; Lynch CJ; Exton JH
    J Biol Chem; 1988 Oct; 263(29):14920-4. PubMed ID: 3139662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
    Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
    Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoaffinity labeling of the V1 vasopressin receptor in plasma membranes from rat liver.
    Boer R; Fahrenholz F
    J Biol Chem; 1985 Dec; 260(28):15051-4. PubMed ID: 2999103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin receptor subtypes in dorsal hindbrain and renal medulla.
    Cornett LE; Dorsa DM
    Peptides; 1985; 6(1):85-9. PubMed ID: 2986082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of vasopressin receptors of rat urinary bladder and spleen.
    Thibonnier M; Snajdar RM; Rapp JP
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H115-20. PubMed ID: 3014903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorpropamide alters AVP-receptor binding of rat renal tubular membranes.
    Muta T; Takasugi M; Kuroiwa A
    Eur J Pharmacol; 1989 Jan; 159(2):191-4. PubMed ID: 2707308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonizes the magnesium-induced high affinity state of the hepatic vasopressin receptor for the agonist interaction.
    Wang H; Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
    Br J Pharmacol; 1990 May; 100(1):5-10. PubMed ID: 2372661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A minor modification of residue 1 in potent vasopressin antagonists dramatically reduces agonist activity.
    Huffman WF; Albrightson-Winslow C; Brickson B; Bryan HG; Caldwell N; Dytko G; Eggleston DS; Kinter LB; Moore ML; Newlander KA
    J Med Chem; 1989 Apr; 32(4):880-4. PubMed ID: 2522994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.